Internal Medicine, Rheumatology · Honolulu, HI
NPI
1295747343
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
550 S Beretania St, Suite 514
Honolulu, HI, 96813
Phone (808) 523-2911
Groups this clinician bills Medicare through
Medicare paid, 2024
$107K
1,251 services
Medicare patients, 2024
287
Average age 76
Drug cost, 2024
$1.5M
3,414 prescriptions
Company payments, 2025
$4,490
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kristine M Uramoto was code 99214 (office e&m - established), 895 times for 285 patients. In total Kristine M Uramoto billed 1,251 services in 17 codes, and Medicare paid $107K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-08-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 895 | 285 | $96.71 | $87K |
| 99213 Office E&M - Established | Office | 78 | 56 | $68.94 | $5,377 |
| 96372 Injection Administration | Office | 62 | 32 | $11.88 | $736 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 56 | 11 | $0.69 | $38.75 |
| 20610 Joint Injection | Office | 46 | 14 | $63.75 | $2,932 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 45 | 45 | $145.12 | $6,530 |
By year: 2022 $105K for 1,225 services; 2023 $102K for 1,246 services; 2024 $107K for 1,251 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kristine M Uramoto prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 314 prescriptions and refills. In total Kristine M Uramoto wrote 3,414 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 314 | 928 | 100 | $30K |
| Methotrexate Methotrexate Sodium | 245 | 674 | 68 | $12K |
| Sulfasalazine Dr Sulfasalazine | 201 | 558 | 54 | $15K |
| Prednisone Generic | 128 | 273 | 38 | $998 |
| Atorvastatin Calcium Generic | 122 | 361 | 35 | $3,799 |
| Gabapentin Generic | 92 | 255 | 30 | $2,305 |
| Alendronate Sodium Generic | 84 | 230 | 27 | $1,618 |
| Levothyroxine Sodium Generic | 82 | 197 | 15 | $588 |
| Losartan Potassium Generic | 81 | 237 | 27 | $1,267 |
| Celecoxib Generic | 72 | 172 | 29 | $3,187 |
| Prolia Denosumab | 70 | 417 | 42 | $124K |
| Meloxicam Generic | 64 | 120 | 26 | $762 |
| Allopurinol Generic | 64 | 190 | 20 | $1,162 |
| Amlodipine Besylate Generic | 57 | 161 | 18 | $932 |
| Mycophenolate Mofetil Generic | 53 | 149 | 19 | $11K |
Brand drugs: - claims; generic drugs: 2,714 claims; opioid claims: 81.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kristine M Uramoto $4,490 ($4,490 in general payments such as food, travel and fees) from 18 companies. The largest payer was Amgen Inc. with $905.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 42 | $905 |
| Abbvie Inc. ABBV | 23 | $705 |
| UCB, Inc. UCB.BR | 30 | $581 |
| Mallinckrodt Hospital Products Inc. | 6 | $443 |
| Genzyme Corporation SNY | 4 | $432 |
| GlaxoSmithKline, LLC. GSK | 8 | $283 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $234 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $220 |
| Janssen Biotech, Inc. JNJ | 4 | $174 |
| Lilly USA, LLC LLY | 4 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.